BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 10747434)

  • 1. Defining quality health care with outcomes assessment while achieving economic value.
    Shaw LJ; Miller DD
    Top Health Inf Manage; 2000 Feb; 20(3):44-54. PubMed ID: 10747434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective value-based assessment of new health care technologies and practices.
    Girod CS; Axene DV
    Manag Care; 2000 Aug; 9(8):38-40, 43-7. PubMed ID: 11186514
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical pathways--an evaluation of its impact on the quality of care in an acute care general hospital in Singapore.
    Cheah J
    Singapore Med J; 2000 Jul; 41(7):335-46. PubMed ID: 11026801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A changing paradigm in the study and adoption of emerging health care technologies: coverage with evidence development.
    Wallner PE; Konski A
    J Am Coll Radiol; 2008 Nov; 5(11):1125-9. PubMed ID: 18954812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies to control costs and quality: a focus on outcomes research for disease management.
    Villagra V
    Med Care; 2004 Apr; 42(4 Suppl):III24-30. PubMed ID: 15026668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved clinical outcomes with compliance in routine use of standard medical therapy in patients with acute coronary syndrome.
    Sharma A; GangiReddy S; Judson K; McAndrews J; Sharma B
    J Cardiovasc Manag; 2004; 15(4):14-7. PubMed ID: 15315152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of clinical effects.
    Teerawattananon Y; Thavorncharoensap M; Mohara A
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S38-42. PubMed ID: 19253486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Alberta Hip and Knee Replacement Project: a model for health technology assessment based on comparative effectiveness of clinical pathways.
    Gooch KL; Smith D; Wasylak T; Faris PD; Marshall DA; Khong H; Hibbert JE; Parker RD; Zernicke RF; Beaupre L; Pearce T; Johnston DW; Frank CB
    Int J Technol Assess Health Care; 2009 Apr; 25(2):113-23. PubMed ID: 19366494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Medical-economic analysis: a necessary complement to "evidence based medicine"].
    Wasserfallen JB
    Rev Med Suisse Romande; 2001 Apr; 121(4):265-8. PubMed ID: 11400397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic evaluation in critical care medicine.
    Cox HL; Laupland KB; Manns BJ
    J Crit Care; 2006 Jun; 21(2):117-24. PubMed ID: 16769454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison analysis. Critics questioning design of effectiveness studies.
    DoBias M
    Mod Healthc; 2009 Feb; 39(8):10. PubMed ID: 19274822
    [No Abstract]   [Full Text] [Related]  

  • 14. Critical pathway for the management of acute heart failure at the Veterans Affairs San Diego Healthcare System: transforming performance measures into cardiac care.
    Gardetto NJ; Greaney K; Arai L; Brenner A; Carroll KC; Howerton NM; Lee M; Pada L; Tseng M; Maisel AS
    Crit Pathw Cardiol; 2008 Sep; 7(3):153-72. PubMed ID: 18791404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management, part I: introduction and general considerations.
    Manchikanti L
    Pain Physician; 2008; 11(2):161-86. PubMed ID: 18354710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic analysis alongside clinical trials: problems and potential.
    Drummond M
    J Rheumatol; 1995 Jul; 22(7):1403-7. PubMed ID: 7562785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Getting to 'smart' health care.
    Clancy CM
    Health Aff (Millwood); 2006; 25(6):w589-92. PubMed ID: 17090557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A primer on the assessment of medical technologies.
    Matuszewski KA
    Pharm Pract Manag Q; 1997 Jan; 16(4):53-65. PubMed ID: 10164160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stratified cost-effectiveness analysis: a framework for establishing efficient limited use criteria.
    Coyle D; Buxton MJ; O'Brien BJ
    Health Econ; 2003 May; 12(5):421-7. PubMed ID: 12720259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ['Medical technology assessment'; more than just efficacy].
    Buskens E
    Ned Tijdschr Geneeskd; 2000 Mar; 144(13):622-6. PubMed ID: 10761552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.